Albemarle Corp. vs Herbalife Nutrition Ltd — how do they compare? Albemarle Corp. trades at $128.54 (market cap $15.27B), while Herbalife Nutrition Ltd trades at $11.76 (market cap $1.23B). The key difference: Albemarle Corp. is far larger — about 12.4× Herbalife Nutrition Ltd's market cap, and Albemarle Corp. pays a 1.27% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| ALB | HLF | |
|---|---|---|
Market Cap | $15.27B | $1.23B |
Sector | Basic Materials | Consumer Staples |
52-Week High | $215.62 | $19.96 |
52-Week Low | $72.58 | $7.75 |
Enterprise Value | $17.75B | $3.06B |
Dividend Yield | 1.27% | — |
Signals from Pluang's Aura AI — not financial advice
Albemarle (ALB) trades at $128.29, down 2.23% today, with mixed technical signals showing bullish moving averages but overbought RSI levels. The company reported strong Q2 2026 results with EPS of $3.75 beating estimates by 17%, driven by improved lithium pricing and specialty chemicals performance. Despite recent profitability challenges with negative net income in 2025, cash flow generation remains healthy at $1.28B from operations.
Analyst consensus leans positive with 42% buy ratings and $184.50 price target representing 44% upside potential. Key risks include lithium price volatility and Q3 margin pressure, while catalysts include sustained demand for energy storage solutions and ongoing balance sheet improvements through debt reduction.
Herbalife (HLF) trades at $11.695, up 1.52% on the day, with a bearish technical outlook per moving averages. The company reported Q2 2026 net sales of $1.3 billion, a 5.4% year-over-year increase, though EPS of $0.51 missed estimates. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24. Positive news includes being named to TIME's America's Best Companies 2026 list, but a planned CFO transition in December 2026 introduces uncertainty.
The outlook is mixed; strong sales growth and low valuation metrics offer potential upside, but recent earnings misses, a high debt load, and negative shareholder equity pose significant risks. Analyst consensus leans bullish with 53.84% buy ratings, yet the stock faces headwinds from competitive pressures and margin volatility.
Trailing returns across standard periods
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →